Genmab — Maj 2024

[peter12]

Interview med Thai https://clinicaledge.xtalks.com/magazine/issue2/breakthroughs-in-antibody-therapeutics

[E_L]

Genmab's Silver Anniversary: Reflecting on 25 Years of Breakthroughs in Antibody Therapeutics

Interviewee: Tahi Ahmadi https://clinicaledge.xtalks.com/magazine/issue2/breakthroughs-in-antibody-therapeutics

[E_L]

peter already posted that i see. another
coffee

[peter12]

It was the short version with typos

[transalp]

Go morgen...

[E_L]

In "Super-Aging" Japan, the Life Sciences Market is Booming https://www.jetro.go.jp/en/invest/insights/japan-insight/lifesciences-market-booming.html

[Riis7]

You nede to be
super aging to see Genmab in new ATH;-)

[Riis7]

need

[StockBull]

skør kurs p.t. Burde ligge over 3500 hvis JNJ opter-ind

[StockBull]

så nemme penge for den spekulative investor som er villig til at tage en risiko på ca. 35% for at JNJ ikke opter-ind. 65% mulighed for at score 1500 kurspoint og 35% risiko for at tabe vel max 500 kurspoint.

[E_L]

Teprotumumab Treats Thyroid Eye Disease Across Age https://www.medscape.com/viewarticle/teprotumumab-treats-thyroid-eye-disease-across-age-2024a1000906?form=fpf

[Raun]

@Riis7 .... Som jeg forstår det, har du ikke aktier i Genmab mere..... Vil du ikke være sød at lade være med at være en del af debatten, så længe du kun kommer med intetsigende kommentarer?

[Goose3]

Novo viser gode resultater
med mim8. Burde der ikke komme noget fra Genmab om det

[Riis7]

Jeg har lidt i pension og tænker alle må skrive om de har aktier eller ej

[ProinvestorNEWS]

Novos blødermedikamant Mim8 når et af sine endemål i dag
https://www.proinvestor.com/boards/120390

[Solsen]

Udsigt til yderligere milestones og royalty

[JKY_VH]

Tak for den PN, det lyder godt;-)

[Bulder]

Ads’en har reageret lidt på det.

[Bulder]

NVO stiger også.

[E_L]

excellent news. I am probably not the only one here to expect a lot from Novo to deliver on this development of the first DuoBody product candidate in an
indication outside of oncology